Vimarsana
Biggest News Aggregation in the World

Page 3 - Peginterferon Lambda News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Peginterferon Lambda. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Peginterferon Lambda Today - Breaking & Trending Today

Eiger BioPharmaceuticals and AnGes Announce Exclusive Partnership for Regulatory Approval and Commercialization of Zokinvy® (lonafarnib) in Japan - Vimarsana News

Eiger BioPharmaceuticals and AnGes Announce Exclusive Partnership for Regulatory Approval and Commercialization of Zokinvy® (lonafarnib) in Japan

/PRNewswire/ -- Eiger Biopharmaceuticals Inc. ("Eiger", Nasdaq: EIGR) and AnGes Inc. ("AnGes", TYO: 4563) today announced that the companies entered into an...

Eiger BioPharmaceuticals and AnGes Announce Exclusive Partnership for Regulatory Approval and Commercialization of Zokinvy® (lonafarnib) in Japan - Vimarsana News

Eiger BioPharmaceuticals and AnGes Announce Exclusive Partnership for Regulatory Approval and Commercialization of Zokinvy® (lonafarnib) in Japan

PALO ALTO, Calif. and OSAKA, Japan, May 10, 2022 /PRNewswire/ -- Eiger Biopharmaceuticals Inc. and AnGes Inc. today announced that the companies entered into an agreement for the regulatory...

Eiger BioPharmaceuticals and AnGes Announce Exclusive Partnership for Regulatory Approval and Commercialization of Zokinvy® (lonafarnib) in Japan - Vimarsana News

Eiger BioPharmaceuticals and AnGes Announce Exclusive Partnership for Regulatory Approval and Commercialization of Zokinvy® (lonafarnib) in Japan

/PRNewswire/ -- Eiger Biopharmaceuticals Inc. ("Eiger", Nasdaq: EIGR) and AnGes Inc. ("AnGes", TYO: 4563) today announced that the companies entered into an...

Eiger BioPharmaceuticals, Inc. (EIGR) CEO David Cory on Q1 2022 Results - Earnings Call Transcript - Vimarsana News

Eiger BioPharmaceuticals, Inc. (EIGR) CEO David Cory on Q1 2022 Results - Earnings Call Transcript

Eiger BioPharmaceuticals, Inc. (NASDAQ:NASDAQ:EIGR) Q1 2022 Earnings Conference Call May 5, 2022 04:30 PM ET Company Participants Sarah Mathieson - Senior Vice President-Corporate Affairs...

Eiger BioPharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Update - Vimarsana News

Eiger BioPharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Update

/PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), a commercial-stage biopharmaceutical company focused on the development of innovative therapies...